Matjaz Bunc
Overview
Explore the profile of Matjaz Bunc including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
588
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Travieso A, Zaid S, Norgaard B, Bunc M, Jilaihawi H, Bapat V, et al.
JACC Cardiovasc Interv
. 2024 Dec;
18(2):276-278.
PMID: 39708016
No abstract available.
2.
Guthoff H, Abdel-Wahab M, Kim W, Witberg G, Wienemann H, Thurow M, et al.
JACC Cardiovasc Interv
. 2024 Nov;
17(22):2626-2635.
PMID: 39603776
Background: Prosthesis-patient mismatch after transcatheter aortic valve replacement (TAVR) can be measured echocardiographically (measured prosthesis-patient mismatch [PPMm]) or predicted (predicted prosthesis-patient mismatch [PPMp]) using published effective orifice area (EOA) reference...
3.
van Royen N, Amat-Santos I, Hudec M, Bunc M, Ijsselmuiden A, Laanmets P, et al.
EuroIntervention
. 2024 Nov;
21(2):e105-e118.
PMID: 39589296
Background: There are limited head-to-head randomised trials comparing the performance of different transcatheter heart valves (THVs). Aims: We aimed to evaluate the non-inferiority of the balloon-expandable Myval THV series compared...
4.
Banach M, Reiner Z, Surma S, Bajraktari G, Bielecka-Dabrowa A, Bunc M, et al.
Drugs
. 2024 Nov;
84(12):1541-1577.
PMID: 39497020
Atherosclerotic cardiovascular disease (ASCVD) and consequent acute coronary syndromes (ACS) are substantial contributors to morbidity and mortality across Europe. Fortunately, as much as two thirds of this disease's burden is...
5.
Mrak M, Zlahtic T, Starc V, Ivanovski M, Bunc M, Zizek D
Rev Cardiovasc Med
. 2024 Jul;
24(12):368.
PMID: 39077099
Background: Treatment with a coronary sinus reducer (CSR) is a new therapeutic option for refractory angina patients. Preclinical studies have shown antiarrhythmic properties of coronary sinus narrowing. The possible antiarrhythmic...
6.
Vitez L, Starc V, Jug B, Bunc M
Rev Cardiovasc Med
. 2024 Jul;
24(5):140.
PMID: 39076751
Background: Degenerative aortic stenosis is an atherosclerotic-like process associated with impaired endothelial and autonomic function. Transcatheter aortic valve implantation (TAVI) has become a treatment of choice for patient with severe...
7.
Sammartino S, Laterra G, Pilgrim T, Amat Santos I, De Backer O, Kim W, et al.
J Clin Med
. 2024 Jun;
13(12).
PMID: 38930026
: To date, data regarding the characteristics and management of obstructive, stable coronary artery disease (CAD) encountered in patients undergoing transcatheter aortic valve implantation (TAVI) are sparse. The aim of...
8.
Baumbach A, van Royen N, Amat-Santos I, Hudec M, Bunc M, Ijsselmuiden A, et al.
Lancet
. 2024 May;
403(10445):2695-2708.
PMID: 38795719
Background: Transcatheter aortic valve implantation is an established, guideline-endorsed treatment for severe aortic stenosis. Precise sizing of the balloon-expandable Myval transcatheter heart valve (THV) series with the aortic annulus is...
9.
Fister M, Mikuz U, Ziberna K, Franco D, Radsel P, Bunc M, et al.
PLoS One
. 2024 May;
19(5):e0303376.
PMID: 38723003
The early unfractionated heparin (UFH) treatment in patients with ST-elevation myocardial infarction (STEMI) is a single-center, open-label, randomized controlled trial. The study population are patients with STEMI that undergo primary...
10.
Witberg G, Levi A, Talmor-Barkan Y, Barbanti M, Valvo R, Costa G, et al.
EuroIntervention
. 2024 Apr;
20(8):e487-e495.
PMID: 38629416
Background: Data on the likelihood of left ventricle (LV) recovery in patients with severe LV dysfunction and severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) and its prognostic value...